Since testing became available in 1996, nearly 1 million people have been screened for BRCA1 and BRCA2, the genetic mutations associated with increasing a woman's lifetime risk of developing breast cancer as much as 87%, according to Myriad Genetics, the diagnostic company that helped isolate the two genes and later developed a test to detect them.
CNN: Why more women are choosing double mastectomies